摘要
随着2019新型冠状病毒病(2019 novel coronavirus disease,COVID-19)疫情的迅速蔓延及全国各地的流行病学统计和诊治经验的积累,目前已明确癌症患者由于免疫力低下,感染2019新型冠状病毒以及感染后预后不良的风险增加。妇科肿瘤占女性恶性肿瘤的18.6%,是妇科常见疾病,因疫情持续中断诊治可能会影响疾病最终转归。部分妇科肿瘤患者出现癌性发热、乏力、纳差、腹痛、白细胞偏低等,与COVID-19难以鉴别诊断,甚至延误治疗,并增加医护人员感染的风险。为了最大程度保护妇科肿瘤患者及医务人员的健康和安全,我们将COVID-19疫情期间妇科肿瘤患者的分类管理和临床诊治的经验和措施进行系统梳理,总结成文供参考。
With the rapid spread of COVID-19(2019 novel coronavirus disease),as well as the accumulation of epidemiological statistics and clinic treatment experience in China,it has been proved that cancer patients have high risk and the poor prognosis of the COVID-19 due to poor immunity.The incidence rate of gynecologic oncology is 18.6%of the female malignant tumors,and gynecologic oncology is a common gynecologic disease.Continuous delayed diagnosis and treatment for gynecologic oncology patient may affect the final outcome.Some gynecological oncology patients have cancer fever,fatigue,poor appetite,abdominal pain,low white blood cells,etc,which are more difficult to differentiate from COVID-19.If the differentiation is not timely,it is easy to delay the treatment,and increase the infection risk of medical staff.In order to protect the health and safety of gynecological oncology patients and medical staff to the greatest extent,we systematically reviewed and summarized the experience of classification management and clinical treatment of gynecological oncology patients during the epidemic of COVID-19.
作者
叶双梅
王世宣
Ye Shuangmei;Wang Shixuan(Department of Obstetrics and Gynecology,Tongji Hospital,Tongji Medical College,Huazhong University of science and technology,Wuhan 430030,China)
出处
《中华转移性肿瘤杂志》
2020年第1期1-5,共5页
Chinese Journal of Metastatic Cancer
关键词
2019新型冠状病毒病
妇科肿瘤
分类管理
临床诊治
2019 novel coronavirus disease
Gynecological oncology
Classification management
Clinical diagnosis and treatment
